title: Comment on "NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis".
abstract: Experimental cancer models must consider the role of the immune system.
authors.affiliation: Department of Cancer Immunotherapy, Genentech, South San Francisco, CA 94080, USA.
authors.forename: Jérémie
authors.initials: J
authors.lastname: Decalf
authors.affiliation: Department of Cancer Immunotherapy, Genentech, South San Francisco, CA 94080, USA.
authors.forename: Rosa Barreira
authors.initials: RB
authors.lastname: da Silva
authors.affiliation: Department of Cancer Immunotherapy, Genentech, South San Francisco, CA 94080, USA.
authors.forename: Scott
authors.initials: S
authors.lastname: Werneke
authors.affiliation: Department of Cancer Immunotherapy, Genentech, South San Francisco, CA 94080, USA. The Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, 75724 Paris, France. INSERM U1223, 75724 Paris, France. albertm7@gene.com.
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Albert
mesh_terms: D000975:Antioxidants; D006801:Humans; D007004:Hypoglycemic Agents; D051267:NF-E2-Related Factor 2; D009369:Neoplasms; D018384:Oxidative Stress
chemical_list: D000975:Antioxidants; D007004:Hypoglycemic Agents; D051267:NF-E2-Related Factor 2